Therapeutic effects of fingolimod through sphingosine-1-phosphate signaling in pulmonary arterial hypertension
{{output}}
Pulmonary arterial hypertension (PAH) is a progressive and life-threatening disease characterized by pulmonary vascular remodeling. This remodeling is primarily caused by abnormal proliferation of pulmonary arterial smooth muscle cells (PASMCs), facilitated by... ...
